The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer.
The global Cancer Immunotherapy market was valued at US$ 49490 million in 2023 and is anticipated to reach US$ 172490 million by 2030, witnessing a CAGR of 20.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cancer Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Immunotherapy.
Report Scope
The Cancer Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Amgen
- AstraZeneca
- Roche
- Bayer
- Bristol-Myers Squibb
- Eli Lilly
- Merck
- Novartis
- Pfizer
Segment by Type
- Immune Checkpoint Inhibitors
- Immune System Modulators
- Cancer Vaccines
Segment by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Immune System Modulators
1.2.4 Cancer Vaccines
1.3 Market by Application
1.3.1 Global Cancer Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Melanoma
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Immunotherapy Market Perspective (2019-2030)
2.2 Cancer Immunotherapy Growth Trends by Region
2.2.1 Global Cancer Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Immunotherapy Historic Market Size by Region (2019-2024)
2.2.3 Cancer Immunotherapy Forecasted Market Size by Region (2025-2030)
2.3 Cancer Immunotherapy Market Dynamics
2.3.1 Cancer Immunotherapy Industry Trends
2.3.2 Cancer Immunotherapy Market Drivers
2.3.3 Cancer Immunotherapy Market Challenges
2.3.4 Cancer Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Immunotherapy Players by Revenue
3.1.1 Global Top Cancer Immunotherapy Players by Revenue (2019-2024)
3.1.2 Global Cancer Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Immunotherapy Revenue
3.4 Global Cancer Immunotherapy Market Concentration Ratio
3.4.1 Global Cancer Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Revenue in 2023
3.5 Cancer Immunotherapy Key Players Head office and Area Served
3.6 Key Players Cancer Immunotherapy Product Solution and Service
3.7 Date of Enter into Cancer Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Immunotherapy Breakdown Data by Type
4.1 Global Cancer Immunotherapy Historic Market Size by Type (2019-2024)
4.2 Global Cancer Immunotherapy Forecasted Market Size by Type (2025-2030)
5 Cancer Immunotherapy Breakdown Data by Application
5.1 Global Cancer Immunotherapy Historic Market Size by Application (2019-2024)
5.2 Global Cancer Immunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Immunotherapy Market Size (2019-2030)
6.2 North America Cancer Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Immunotherapy Market Size by Country (2019-2024)
6.4 North America Cancer Immunotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Immunotherapy Market Size (2019-2030)
7.2 Europe Cancer Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Immunotherapy Market Size by Country (2019-2024)
7.4 Europe Cancer Immunotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Immunotherapy Market Size (2019-2030)
8.2 Asia-Pacific Cancer Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Immunotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Immunotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Immunotherapy Market Size (2019-2030)
9.2 Latin America Cancer Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Immunotherapy Market Size by Country (2019-2024)
9.4 Latin America Cancer Immunotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Immunotherapy Market Size (2019-2030)
10.2 Middle East & Africa Cancer Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Immunotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Immunotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Immunotherapy Introduction
11.1.4 Amgen Revenue in Cancer Immunotherapy Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cancer Immunotherapy Introduction
11.2.4 AstraZeneca Revenue in Cancer Immunotherapy Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Cancer Immunotherapy Introduction
11.3.4 Roche Revenue in Cancer Immunotherapy Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Cancer Immunotherapy Introduction
11.4.4 Bayer Revenue in Cancer Immunotherapy Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Cancer Immunotherapy Introduction
11.5.4 Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Cancer Immunotherapy Introduction
11.6.4 Eli Lilly Revenue in Cancer Immunotherapy Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Cancer Immunotherapy Introduction
11.7.4 Merck Revenue in Cancer Immunotherapy Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Cancer Immunotherapy Introduction
11.8.4 Novartis Revenue in Cancer Immunotherapy Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Cancer Immunotherapy Introduction
11.9.4 Pfizer Revenue in Cancer Immunotherapy Business (2019-2024)
11.9.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
